KIMS.NS Profit & Loss
Krishna Institute of Medical Sciences Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:35
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Revenue from Operations | ₹2,197.68 Cr. | ₹2,498.14 Cr. | ₹3,035.10 Cr. | ₹3,904.60 Cr. | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | N/A | N/A | N/A | SegmentRevenueFromOperations |
| Other Income | ₹25.87 Cr. | ₹13.06 Cr. | ₹31.90 Cr. | ₹26.20 Cr. | OtherIncome |
| Total Income | ₹2,223.55 Cr. | ₹2,511.20 Cr. | ₹3,067.00 Cr. | ₹3,930.80 Cr. | Income |
| Cost of Materials Consumed | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹474.49 Cr. | ₹536.87 Cr. | ₹640.40 Cr. | ₹841.80 Cr. | PurchasesOfStockInTrade |
| Changes in Inventories | ₹6.16 Cr. | ₹-6.58 Cr. | ₹-13.50 Cr. | ₹-32.90 Cr. | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹346.44 Cr. | ₹422.37 Cr. | ₹499.50 Cr. | ₹681.70 Cr. | EmployeeBenefitExpense |
| Finance Costs | ₹30.55 Cr. | ₹47.03 Cr. | ₹90.30 Cr. | ₹202.50 Cr. | FinanceCosts |
| Depreciation and Amortisation | ₹129.26 Cr. | ₹146.55 Cr. | ₹177.20 Cr. | ₹283.20 Cr. | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹766.58 Cr. | ₹905.06 Cr. | ₹1,125.80 Cr. | ₹1,612.00 Cr. | OtherExpenses |
| Total Expenses | ₹1,753.47 Cr. | ₹2,051.29 Cr. | ₹2,519.70 Cr. | ₹3,588.30 Cr. | Expenses |
| Profit Before Exceptional Items and Tax | ₹470.08 Cr. | ₹459.91 Cr. | ₹547.30 Cr. | ₹342.50 Cr. | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹14.83 Cr. | ₹0.00 Cr. | ₹10.80 Cr. | ₹-11.20 Cr. | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹484.91 Cr. | ₹459.91 Cr. | ₹558.10 Cr. | ₹331.30 Cr. | ProfitBeforeTax |
| Tax Expense | ₹119.09 Cr. | ₹123.63 Cr. | ₹143.30 Cr. | ₹91.90 Cr. | TaxExpense |
| Net Profit (incl. minority interest) | ₹365.81 Cr. | ₹336.01 Cr. | ₹414.80 Cr. | ₹242.00 Cr. | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹336.32 Cr. | ₹310.15 Cr. | ₹384.50 Cr. | ₹241.40 Cr. | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹42.03 | ₹38.75 | ₹9.61 | ₹6.03 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹42.03 | ₹38.75 | ₹9.61 | ₹6.03 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from KIMS.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).